SavedAdd your journal

Journals / The Journal of Pediatric Research / 2019 / Cilt: 6 - Sayı: 2

Investigations of Microtubule-associated Protein 2 Gene Expression in Spinal Muscular Atrophy

Gamze BORA
Ceren SUCULARLI
Niko HENSEL
Peter CLAUS
Hayat Erdem YURTER
Pages
148–154
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Upregulation was alsodetected in the brain and spinal cord tissues of severe SMA mice at different developmental stages.Conclusion: Our findings suggest that microtubule regulatory proteins may be altered in SMN depleted cells and further research is neededto elucidate the contribution of dysregulated microtubule dynamics towards SMA.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Spinal muscular atrophy (SMA) is a devastating genetic disease in childhood andff is caused by the absence of functional survival motorneuron (SMN) protein, which leads to impairments of the cytoskeleton, especially in neurons.
📊
Key Findings & Data:We foundaltered expressions of microtubule-associated protein 2 (MAP2), which was validated by real time reverse-transcription polymerase chainreaction using the SMN knock-down NSC34 cell line and the severe SMA mouse model.Results: We showed that the expression of MAP2 gene was significantly upregulated in both expression arrays.
💡
Conclusion & Impact:Upregulation was alsodetected in the brain and spinal cord tissues of severe SMA mice at different developmental stages.Conclusion: Our findings suggest that microtubule regulatory proteins may be altered in SMN depleted cells and further research is neededto elucidate the contribution of dysregulated microtubule dynamics towards SMA.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aim: Spinal muscular atrophy (SMA) is a devastating genetic disease in childhood andff is caused by the absence of functional survival motorneuron (SMN) protein, which leads to impairments of the cytoskeleton, especially in neurons. Dysregulation of actin dynamics have beenlinked to SMA patho mechanisms, however involvement of altered microtubule dynamics is largely unknown. In this study, we investigateddifferentially expressed microtubule-related genes using in vitro and in vivo SMA model systems.Materials and Methods: By focusing on microtubule-related genes, we re-analyzed publically available gene expression arrays, which werepreviously performed with induced pluripotent stem cell-derived motor neurons of SMA patients and the spinal cords of SMA mice. We foundaltered expressions of microtubule-associated protein 2 (MAP2), which was validated by real time reverse-transcription polymerase chainreaction using the SMN knock-down NSC34 cell line and the severe SMA mouse model.Results: We showed that the expression of MAP2 gene was significantly upregulated in both expression arrays. Upregulation was alsodetected in the brain and spinal cord tissues of severe SMA mice at different developmental stages.Conclusion: Our findings suggest that microtubule regulatory proteins may be altered in SMN depleted cells and further research is neededto elucidate the contribution of dysregulated microtubule dynamics towards SMA.

🔖

Cite This Article

BORA, G., SUCULARLI, C., HENSEL, N., CLAUS, P., YURTER, H. E. (2019). Investigations of Microtubule-associated Protein 2 Gene Expression in Spinal Muscular Atrophy. The Journal of Pediatric Research, Cilt: 6 - Sayı: 2, 148–154. https://ajindex.com/articles/362902

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Sugarman EA, Nagan N, Zhu H, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72.400 specimens. Eur J Hum Genet 2012;20:27-32
  2. Munsat TL, Davies KE. International SMA consortium meeting. (26-28 June 1992, Bonn, Germany). Neuromuscul Disord 1992;2:423-8
  3. Pearn J. Classification of spinal muscular atrophies. Lancet 1980;1:919-22
  4. Erdem H, Pehlivan S, Topaloglu H, Ozgüç M. Deletion analysis in Turkish patients with spinal muscular atrophy. Brain Dev 1999;21:86-9
  5. Lefebvre S, Burglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995;80:155-65
  6. Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat 2000;15:228-37
  7. Bowerman M, Shafey D, Kothary R. Smn depletion alters profilin II expression and leads to upregulation of the RhoA/ ROCK pathway and defects in neuronal integrity. J Mol Neurosci 2007;32:120-31
  8. Hao le T, Duy PQ, Jontes JD, Wolman M, Granato M, Beattie CE. Temporal requirement for SMN in motoneuron development. Hum Mol Genet 2013;22: 2612-25
  9. McWhorter ML, Monani UR, Burghes AH, Beattie CE. Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J Cell Biol 2003;162:919-31
  10. Ohuchi K, Funato M, Kato Z, et al. Established stem cell model of spinal muscular atrophy is applicable in the evaluation of the efficacy of thyrotropin-releasing hormone analog. Stem Cells Transl Med 2016;5:152-63
  11. Rossoll W, Jablonka S, Andreassi C, et al. Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J Cell Biol 2003;163:801-12
  12. Hosseinibarkooie S, Peters M, Torres-Benito L, et al. The power of human protective modifiers: PLS3 and CORO1C unravel impaired endocytosis in spinal muscular atrophy and rescue SMA Phenotype. Am J Hum Genet 2016;99:647-65
  13. Nolle A, Zeug A, van Bergeijk J, et al. The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin. Hum Mol Genet 2011;20:4865-78
  14. Miller N, Feng Z, Edens BM, et al. Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy. J Neurosci 2015;35:6038-50
  15. Wen HL, Lin YT, Ting CH, Lin